2468-0249

Kidney International Reports

Elsevier

View prefix report (10.1016)

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 14123 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact14123 DOIs
2

Attach ORCID iDs across 13417 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact13417 DOIs
3

Deposit reference lists for 10592 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact10592 DOIs

DOIs for this ISSN

Showing the top 5 of 10000 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Chronic Inflammation in Chronic Kidney Disease Progression:… (10.1016/j.ekir.2021.04.023)
Abstract ORCID
122.28 278
2 Depression in Chronic Kidney Disease and End-Stage Renal Dis… (10.1016/j.ekir.2016.09.005)
Abstract ORCID
120.92 261
3 Collapsing Glomerulopathy in a Patient With COVID-19 (10.1016/j.ekir.2020.04.002)
Abstract ORCID
119.98 250
4 The Obesity Paradox in Kidney Disease: How to Reconcile It W… (10.1016/j.ekir.2017.01.009)
Abstract ORCID
114.94 198
5 Acute Kidney Injury Due to Collapsing Glomerulopathy Followi… (10.1016/j.ekir.2020.04.017)
Abstract ORCID
113.12 182
6 Management of Patients on Dialysis and With Kidney Transplan… (10.1016/j.ekir.2020.04.001)
Abstract ORCID
112.88 180
7 Occupational Heat Stress and Kidney Health: From Farms to Fa… (10.1016/j.ekir.2017.08.012)
Abstract ORCID
110.34 160
8 Segmentation of Glomeruli Within Trichrome Images Using Deep… (10.1016/j.ekir.2019.04.008)
Abstract ORCID
109.93 157
9 DNAJB9 Is a Specific Immunohistochemical Marker for Fibrilla… (10.1016/j.ekir.2017.07.017)
Abstract ORCID
109.38 153
10 CKD-Associated Pruritus: New Insights Into Diagnosis, Pathog… (10.1016/j.ekir.2020.04.027)
Abstract ORCID
109.38 153
11 The Renal Pathology of Obesity (10.1016/j.ekir.2017.01.007)
Abstract ORCID
108.95 150
12 POS-546 EFFICACY AND SAFETY OF IPTACOPAN IN IgA NEPHROPATHY:… (10.1016/j.ekir.2022.01.577)
Abstract References ORCID
108.54 27
13 Bariatric Surgery and Kidney-Related Outcomes (10.1016/j.ekir.2017.01.010)
Abstract ORCID
108.07 144
14 Safety, Tolerability and Efficacy of Narsoplimab, a Novel MA… (10.1016/j.ekir.2020.08.003)
Abstract ORCID
107.92 143
15 Endemic Nephropathy Around the World (10.1016/j.ekir.2016.11.003)
Abstract ORCID
107.61 141
16 Preventing CKD in Developed Countries (10.1016/j.ekir.2019.12.003)
Abstract ORCID
107.46 140
17 Association of Pathological Fibrosis With Renal Survival Usi… (10.1016/j.ekir.2017.11.002)
Abstract ORCID
106.19 132
18 A Phase 2, Double-Blind, Placebo-Controlled, Randomized Stud… (10.1016/j.ekir.2017.03.011)
Abstract ORCID
105.53 128
19 Constipation in CKD (10.1016/j.ekir.2019.11.002)
Abstract ORCID
105.53 128
20 Serum Creatinine in Pregnancy: A Systematic Review (10.1016/j.ekir.2018.10.015)
Abstract ORCID
105.02 125
21 De Novo ANCA-Associated Vasculitis With Glomerulonephritis i… (10.1016/j.ekir.2020.08.012)
Abstract ORCID
103.78 118
22 Randomized Clinical Trial on the Effect of Bardoxolone Methy… (10.1016/j.ekir.2020.03.030)
Abstract ORCID
103.59 117
23 Overview of Antibiotic-Induced Nephrotoxicity (10.1016/j.ekir.2023.08.031)
Abstract ORCID
103.59 117
24 Hyponatremia and the Brain (10.1016/j.ekir.2017.08.015)
Abstract ORCID
103.03 114
25 Strategies for Phosphate Control in Patients With CKD (10.1016/j.ekir.2019.06.002)
Abstract ORCID
102.46 111
26 Immune Checkpoint Inhibitors and Immune-Related Adverse Rena… (10.1016/j.ekir.2020.04.018)
Abstract ORCID
101.06 104
27 COVID-19–Associated Collapsing Glomerulopathy: An Emerging E… (10.1016/j.ekir.2020.04.030)
Abstract ORCID
101.06 104
28 Obinutuzumab is Effective for the Treatment of Refractory Me… (10.1016/j.ekir.2020.06.030)
Abstract ORCID
101.06 104
29 Roxadustat for CKD-related Anemia in Non-dialysis Patients (10.1016/j.ekir.2020.11.034)
Abstract ORCID
101.06 104
30 POS-112 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBIT… (10.1016/j.ekir.2022.01.124)
Abstract References ORCID
100.68 21
31 Total Kidney Volume Is a Prognostic Biomarker of Renal Funct… (10.1016/j.ekir.2017.01.003)
Abstract ORCID
100.64 102
32 Complement in Secondary Thrombotic Microangiopathy (10.1016/j.ekir.2020.10.009)
Abstract ORCID
100.43 101
33 Adverse Renal Effects of Novel Molecular Oncologic Targeted… (10.1016/j.ekir.2016.09.055)
Abstract ORCID
100.00 99
34 Secondary Oxalate Nephropathy: A Systematic Review (10.1016/j.ekir.2018.07.020)
Abstract ORCID
100.00 99
35 Treatment of Calciphylaxis in CKD: A Systematic Review and M… (10.1016/j.ekir.2018.10.002)
Abstract ORCID
100.00 99
36 Anticancer Drug-Induced Acute Kidney Injury (10.1016/j.ekir.2017.02.008)
Abstract ORCID
99.56 97
37 Efficacy and Safety of Iptacopan in Patients With C3 Glomeru… (10.1016/j.ekir.2023.09.017)
Abstract ORCID
99.56 97
38 Sarcopenia, Obesity, and Mortality in US Adults With and Wit… (10.1016/j.ekir.2016.10.008)
Abstract ORCID
99.11 95
39 Profiling of Plasma Metabolites Suggests Altered Mitochondri… (10.1016/j.ekir.2016.12.003)
Abstract ORCID
99.11 95
40 A Randomized Trial of Roxadustat in Anemia of Kidney Failure… (10.1016/j.ekir.2021.04.007)
Abstract ORCID
98.66 93
41 Paraffin Immunofluorescence: A Valuable Ancillary Technique… (10.1016/j.ekir.2018.07.008)
Abstract ORCID
98.42 92
42 Randomized Phase II JANUS Study of Atacicept in Patients Wit… (10.1016/j.ekir.2022.05.017)
Abstract ORCID
98.42 92
43 Combination Therapy With Rituximab and Cyclophosphamide for… (10.1016/j.ekir.2017.11.004)
Abstract ORCID
98.19 91
44 The Social Media Revolution in Nephrology Education (10.1016/j.ekir.2018.02.003)
Abstract ORCID
98.19 91
45 Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 S… (10.1016/j.ekir.2023.08.033)
Abstract ORCID
97.22 87
46 Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Ur… (10.1016/j.ekir.2017.06.004)
Abstract ORCID
96.98 86
47 High Prevalence of CKD of Unknown Etiology in Uddanam, India (10.1016/j.ekir.2018.10.006)
Abstract ORCID
96.98 86
48 Renal Recovery for Patients with ANCA-Associated Vasculitis… (10.1016/j.ekir.2023.01.039)
Abstract ORCID
96.98 86
49 Natural History and Genotype–Phenotype Correlation in Female… (10.1016/j.ekir.2017.04.011)
Abstract ORCID
96.72 85
50 Lipidomic Signature of Progression of Chronic Kidney Disease… (10.1016/j.ekir.2016.08.007)
Abstract ORCID
96.21 83